New Advances in the Role of Regulatory T Cells in Immunity
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 1658
Special Issue Editor
Special Issue Information
Dear Colleagues,
Numerous diseases, such as allergies, autoinflammatory conditions, and autoimmune disorders, disrupt immune regulation. This disruption signifies a fundamental breakdown of the mechanisms that normally control excessive immune responses. One critical aspect of this regulation involves regulatory T cells (Treg cells), which are responsible for maintaining immunological tolerance in peripheral tissues towards one’s own antigens, friendly bacteria, and harmless foreign substances.
The objective of this Special Issue is to compile an extensive collection of articles focused on recent advancements in the field of regulatory T cells and their role in immune systems. This Special Issue will encompass a wide spectrum of Treg-related subjects, ranging from fundamental research to translational studies. We eagerly invite submissions of original research articles, and reviews on a broad range of topics including, but not limited to, the following:
- Cutting-edge developments in regulatory T cells and their function in immunity;
- Exploring the role of Treg cells in allergic, autoinflammatory, and autoimmune disorders;
- Translational applications of Treg cell research in clinical settings;
- Mechanisms of Treg cell-mediated immune response (immunosuppression, tissue repair, and others);
- Novel therapeutic strategies targeting Treg cells in immune-related diseases.
Dr. Mehdi Benamar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- regulatory T cells
- immune regulation
- autoimmune diseases
- tolerance
- Foxp3
- immunomodulatory therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
